Member Login
  1. Stocks
    2. /
  2. AbCellera Biologics Inc. (NASDAQ: ABCL)
    3. /

NASDAQ:ABCL (AbCellera Biologics Inc.)

About ABCL

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • AbCellera Biologics Inc. (NASDAQ: ABCL) Latest News

    Investing

    The Best Canadian Stock You’ve Never Heard of

    | Aditya Raghunath

    Down over 90% from all-time highs, AbCellera Biologics is a Canadian stock with significant upside potential.

    Read more »

    Workers use a microscope to do medical research in a modern laboratory.
    Tech Stocks

    These Canadian Biotech Stocks Are Quietly Changing the Face of Healthcare

    | Brian Paradza, CFA

    Canadian biotech stock BELLUS Health has been snatched from the public market. However, these two biopharma growth stocks also have…

    Read more »

    lab worker inspects test tubes
    Investing

    AbCellera Biologics Stock: Here’s What’s Coming in 2023

    | Ambrose O'Callaghan

    AbCellera Biologics Inc. (NASDAQ:ABCL) is a biotech stock that has explosive potential as we wade through the opening month of…

    Read more »

    Piggy bank wrapped in Christmas string lights
    Investing

    Just Released: The 5 Best Stocks to Buy in December 2022 [PREMIUM PICKS]

    | Nate Parmelee (TMFDoraemon)

    Premium content from Motley Fool Stock Advisor Canada “Best Buys Now” Pick #1: AbCellera (NASDAQ:ABCL) AbCellera Biologics (NASDAQ:ABCL) develops antibodies to…

    Read more »